T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell. (2019)
Attributed to:
The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.00437
PubMed Identifier: 30941124
Publication URI: http://europepmc.org/abstract/MED/30941124
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in immunology
ISSN: 1664-3224